| Full Name | Tiffany Keith |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 730 Kimole Ln, Adrian, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003287202 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 5201006900 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Tiffany Keith, 730 Kimole Ln, Adrian, MI 49221-1463 Ph: (517) 263-6771 | Tiffany Keith, 730 Kimole Ln, Adrian, MI 49221-1463 Ph: (517) 263-6771 |
News Archive
The Harvard Clinical Research Institute (HCRI) announced today that the DAPT Study has expanded into Australia and New Zealand. Professor Ian Meredith, MBBS, Ph.D., interventional cardiologist at MonashHeart in Melbourne, Australia and National Coordinating Investigator for the DAPT Study in Australia, was the first Pacific Rim investigator to enroll patients into the study.
Alexza Pharmaceuticals, Inc. announced today that it has entered into a definitive agreement with various institutional investors to raise $19.7 million in a private placement of its common stock.
The lives of patients hospitalized with COVID-19 are being saved by doctors who are using an existing medical treatment at an earlier stage.
Medecins Sans Frontieres and Oxfam on Tuesday called on developed nations to adhere to the World Trade Organization's Agreement on Trade-Related Aspects of Intellectual Property Rights to ensure universal access to antiretroviral drugs in developing countries, the AP/International Herald Tribune reports (Higgins, AP/International Herald Tribune, 11/14).
Millennium: The Takeda Oncology Company today announced the initiation of a Phase II clinical trial examining rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) with or without VELCADE® (bortezomib) for Injection for patients with a common type of lymphoma. The study will examine previously untreated patients with a genomically defined subtype of lymphoma called non-germinal center B-cell-like (non-GCB) diffuse large B-cell lymphoma.
› Verified 3 days ago
Laura M Ernst, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1200 Corporate Dr, Adrian, MI 49221 Phone: 517-264-2790 | |
Jason Higgins, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 730 Riverside Ave, Adrian, MI 49221 Phone: 517-266-1700 | |
Lisa Ritz, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1800 W Us Highway 223, Adrian, MI 49221 Phone: 517-263-3378 Fax: 517-263-4527 | |
Kassidy Lyn Roe, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 Sand Creek Hwy, Adrian, MI 49221 Phone: 517-263-6794 | |
Stephanie Olszewski, OT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1424 S Main St, Adrian, MI 49221 Phone: 517-312-1712 Fax: 517-312-1711 | |
Ms. Lori A Scouten, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 730 Riverside Ave, Adrian, MI 49221 Phone: 517-266-1700 |